BIO VITOS PHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1195 SEK | +10.65% |
|
-25.78% | -49.79% |
| 02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 02-14 | Bio Vitos Pharma AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Bio Vitos Pharma AB, formerly Hemcheck Sweden AB, is a Sweden-based medical technology company. The Company produces and commercializes a service for near-patient detection of hemolysis in blood samples. The concept consists of disposable tests as well as readers that can quickly, directly upon sampling, identify hemolysed blood samples in vacuum tubes and blood gas syringes. The Company's, ruptured red blood cells, is a common reason globally why blood samples cannot be analyzed accurately and is also a biomarker for acute medical conditions. Its goal is to contribute to improved healthcare by offering user-friendly solutions for the detection of hemolysed blood samples in direct connection with blood sampling near the patient. By doing so, the Company can contribute to increased patient safety, more efficient processes and lower costs.
| 1st Jan change | Capi. | |
|---|---|---|
| -49.79% | 2.97M | |
| -4.67% | 12.33B | |
| -5.19% | 8.14B | |
| +28.50% | 5.62B | |
| -8.09% | 4.24B | |
| -55.31% | 3.06B | |
| +13.49% | 2.76B | |
| -1.34% | 2.41B | |
| +32.24% | 2.23B | |
| -3.55% | 1.87B |
- Stock Market
- Equities
- BIOVIT Stock
- News Bio Vitos Pharma AB
- Bio Vitos Pharma Teams Up with KFUM Kalmar to Explore Benefits of Iron Succinate for Female Athletes